⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Paraganglioma Market Trends and Investment Opportunities 2026-2030
globenewswire.com
MRK
Recurrent Head and Neck Cancer Squamous Cell Carcinoma Markets and Competition Outlook 2026-2030: Personalized Medicine Drives Revenue Growth, Reaching $4.61 Billion by 2030
globenewswire.com
AZN
ABBV
BMY
MRK
Uveal Neoplasms Markets, Companies, and Investment Opportunities Analysis 2026-2030
globenewswire.com
PFE
MRK
IDYA
BMY
MDT
Non-Muscle Invasive Bladder Cancer (NMIBC) Market to Grow by $1 Billion During 2026-2030 - Johnson & Johnson, Janssen Research & Development, and Merck & Co. Lead the Competition
globenewswire.com
JNJ
MRK
IBRX
AZN
$28+ Billion Cancer Supportive Care Products Market Outlook Report, 2030
globenewswire.com
JNJ
MRK
ABBV
ABT
NVS
GSK
AMGN
TEVA
JAGX
LLY
Cancer Cachexia Market Outlook Report 2026-2030: Personalized Treatments and Digital Tools Elevate Cancer Cachexia Care; Total Revenue to Grow by $600 Million
globenewswire.com
PFE
MRK
ABBV
AZN
SNY
Non-Small Cell Lung Cancer (NSCLC) Global Market Trends and Regional Growth Insights 2026-2030: Rapid Adoption of Targeted Therapies and Immunotherapy Fuels Market Expansion, Reaching $70.8 Billion by 2030
globenewswire.com
PFE
MRK
ABBV
NVS
SNY
BMY
AZN
GSK
Esophageal Cancer Market to Grow from $1.65 Billion in 2026 to $2.37 Billion by 2030: Pfizer, Roche, Merck & Co. Dominate
globenewswire.com
PFE
MRK
NVS
PRPH
4BIO Capital strengthens investment leadership with appointment of Therese Liechtenstein as Partner and Tetsu Maruyama as Venture Partner
globenewswire.com
ARCC
CDTX
MRK
GSK
Positive Data from Phase 2 CADENCE Trial Provides Definitive Proof-of-Concept for WINREVAIR™ (sotatercept-csrk) in Adults With the Syndrome of Combined Post- and Precapillary Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction
businesswire.com
MRK